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In the recent scale-up of antiretroviral treatment, gender differences in access to treatment have been
reported. In Thailand, as the HIV epidemic became more generalised, there has been a shift from men
being disproportionately affected to increased vulnerability of women. In 2007, the Living with Anti-
retrovirals (LIWA-ANRS 12141) study investigated the gender distribution of all adult patients receiving
antiretroviral therapy (N¼ 513 patients) in four community hospitals in northern Thailand and factors
inﬂuencing the disparities observed. From this retrospective life-event history survey, we found that
proportionately more women (53%) were receiving antiretroviral therapy than men, an unexpected result
for a country with a higher proportion of infections among men. They were more likely to initiate
treatment within one year of diagnosis and were at a more advanced stage of the disease compared to
women. This gender distribution is partly explained by the evolving dynamics of the HIV epidemic, initial
prioritization of mothers for treatment and earlier access to HIV testing for women. These issues are also
entangled with gender differences in the reasons and timing to HIV testing at the individual level. This
study found that the majority of men underwent HIV testing for health reasons while the majority of
women were tested following family events such as a spouse/child death or during pregnancy. Further
qualitative research on gender speciﬁc barriers to HIV testing and care, such as perceived low risk of
infection, poor access tomedical care, lack of social support, actual or anticipated HIV/AIDS-related stigma
would provide greater insight. In the meantime, urgent efforts are needed to increase access to voluntary
counselling and testing inside and outside the family setting with targeted interventions for men.
 2009 Elsevier Ltd. All rights reserved.Introduction
Thailand was the ﬁrst Asian country affected by the AIDS
epidemic in the late 1980s. It is estimated that over 1 million of the
64 million population has been infected with HIV of which over
460,000 have died (UNDP, 2004). At the end of 2007, there were an
estimated 610,000 persons living with HIV (UNAIDS &WHO, 2008).Gender distribution among HIV infected persons in Thailand
In 1989, the initial wave of the epidemic developed very rapidly
through mostly men intravenous drug users. The second wave was
predominatelyspreadamongcommercial sexworkerswhile the thirdDe´mographiques, 133 Boule-
15; fax: þ33 1 56 06 21 94.
All rights reserved.wave diffused into the general heterosexual population, initially from
commercial sex workers to their clients, and then from the clients to
their regular spouses (Weniger et al., 1991). The second and third
waves of the epidemic were closely related to gender speciﬁc sexual
norms (Brown, Sittitrai, Vanichseni, & Thisyakorn, 1994; Brown &
Xenos,1994; Ford&Koetsawang,1991). Formen, visits to commercial
sexworkers beforemarriagewerewidely accepted as a formof sexual
initiation,whileaftermarriage,visits to commercial sexworkersoften
occurred in the company of peers andwere generally tolerated by the
spouse (Maticka-Tyndale et al., 1997; Saengtienchai, Knodel, Van-
Landingham, & Pramualratana, 1999; Vanlandingham, Knodel,
Saengtienchai, & Pramualratana, 1998). However, women were
traditionally expected to be abstinent before marriage, and extra-
marital sexual relationships were considered socially unacceptable
(Knodel, Saengtienchai, Vanlandingham, & Lucas, 1999).
While HIV prevalence rates in Thailand are remarkably well
documented among speciﬁc populations such as pregnant women,
military conscripts, men who have sex with men, direct and
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reliable data on the overall sex-ratio in HIV infected adults (UNAIDS
& WHO, 2008). There is growing concern for the increased
vulnerability of women following the dramatic decrease in the
male to female sex-ratio of reported AIDS cases, from 6.8:1 in 1992
to 4.4:1 in 1996 (Rerks-Ngarm, 1997). This trend appears to be
continuing with the sex-ratio of reported AIDS cases decreasing
further to 2.4:1 in 1999 (World Bank, 2000) and to 1.6:1 in 2007
(Ministry of Public Health, 2008). This is close to the UNAIDS, 2007
estimate that 250,000 of the 600,000 adults livingwith HIV/AIDS in
Thailand were women, which represents a male to female sex-ratio
of about 1.4:1 (UNAIDS & WHO, 2008).National AIDS program
The Thai government made considerable efforts to curtail the
HIV epidemic with a multi-sectoral AIDS program implemented
beginning in 1989. Among the preventive strategies, the 100%
condom campaign was uniquely successful in limiting the number
of new infections in the general population by increasing the use of
condoms among commercial sex workers and reducing the
frequency of commercial sex visits (Ainsworth, Beyrer, & Soucat,
2003; Hanenberg, Rojanapithayakorn, Kunasol, & Sokal, 1994;
Nelson et al., 1996; Phoolcharoen, Ungchusak, Sittitrai, & Brown,
1998; Rojanapithayakorn & Hanenberg, 1996; UNAIDS, 2000).
However, the prevalence remains high among the predominantly
male high risk behavior populations such as injecting drug users,
and men who have sex with men (Nelson et al., 2002; UNAIDS,
2007; van Griensven et al., 2005).
In terms of provision of antiretroviral treatment, the Depart-
ment of Health piloted the Access to Care (ATC) treatment program
in 2002, which prioritized HIV infected mothers. HIV infected
pregnant women were identiﬁed at the antenatal clinic (ANC)
through HIV screening and enrolled in the national Prevention of
Mother to Child Transmission (PMTCT) of HIV program. This
program, which had a very high antenatal HIV testing acceptance
rate of 97%, led to a dramatic decrease in the number of pediatric
AIDS cases (Amornwichet et al., 2002). The strong association
between maternal and child health was the rationale for priori-
tizing HIV infected new mothers who, if treated, would be able to
raise their children, therefore reducing the burden of orphans. The
ATC program then expanded under the family centered approach of
‘‘PMTCT-Plus’’, which incorporated voluntary HIV counselling and
testing and antiretroviral treatment for infected husbands/partners
and children.
It is important to note that a major health care reform was
implemented in 2001, with the introduction of a universal
coverage system, providing health care at very low patient fees
of ‘‘30-baht’’ (US$0.75) per hospital visit to all Thai citizens
(Tangcharoensathien, Wibulpholprasert, & Nitayaramphong,
2004). The universal coverage system is predominately targeted
towards low income families and runs in parallel with other
existing health coverage schemes – the Social Security Scheme
(SSS), the Workmen’s Compensation Fund (WCF) for workers in
the private sector, the Civil Servant Medical Beneﬁt Scheme
(CSMBS) for government employees and some private insurance
programs. For HIV infected patients, the government launched
the National Access to Antiretroviral Treatment Program
(NAPHA) in 2003, providing free access to antiretroviral therapy
(Chasombat, Lertpiriyasuwat, Thanprasertsuk, Suebsaeng, & Lo,
2006). This program was subsequently integrated with the
universal coverage system. By the end of 2007, the scale-up of
antiretroviral treatments was estimated to have reached 153,000
persons (UNAIDS & WHO, 2008).Gender, HIV and antiretroviral treatment programs
There have been increasing reports of over-representation of
women enrolled in antiretroviral treatments programs compared
to men in lower or middle income countries, in proportion to the
number of HIV infected persons by gender (Braitstein et al., 2008;
Muula et al., 2007). In addition, it appears that men in these
settings aremore likely to present late for testing, at more advanced
stages of the disease and with greater risk of mortality compared to
women (Keiser et al., 2008; Lawn & Wood, 2006) .
In Thailand, a full evaluation of the gender distribution among
adults in the national antiretroviral program has not been con-
ducted. It has been suggested that Thai women were either equally
or over-represented in antiretroviral treatment programs (Brait-
stein et al., 2008; Leusaree, Srithanaviboonchai, Chanmangkang,
Ying-Ru, & Natpratan, 2002). While there have been studies in
Southern Africa (Muula et al., 2007) on the reasons for gender
based differences in access to HIV care, there are limited data in the
Asian setting (Braitstein et al., 2008; Keiser et al., 2008) and, to our
knowledge, no comprehensive study in Thailand.
In this paper, we conducted a life-event history survey of all
adults receiving antiretroviral therapy in four hospitals in a semi-
urban population in Northern Thailand, from which we conducted
a gender based descriptive analysis. This approach enabled us to
relate the gender distribution in access to antiretroviral treatments
with the reasons and timing of HIV testing in the context of the
individual life-course and the evolving AIDS epidemic in Thailand.
Methods
Data were collected from the ‘‘Living with Antiretrovirals’’ study
(LIWA), a socio-demographic and economic evaluation of the
impact of access to antiretroviral treatments in northern Thailand,
a region heavily affected by HIV. The study targeted all HIV infected
adults receiving antiretroviral treatment in four community
hospitals (Mae On, San Sai, Doi Saket and Sankaempeng Hospitals)
in Chiang Mai province.
Life-event history survey
In order to assess the access to antiretroviral treatments and their
socio-demographic impacton the lives of patients, several approaches
could be envisioned. The epidemiological approach would follow
prospectivelyapopulationofHIV infected individuals fromthe timeof
their diagnosis, and assess the changes in their situation by inter-
viewing them at different time points, in particular after treatment
initiation. However, such an approach has huge logistical require-
ments due to the long follow-up duration andwould need to address
issues of attrition related to loss to follow-up.An alternative approach,
chosen here, is a retrospective life-event history survey where
participants are interviewed about their personal history. This
approach is derived from demographic studies (Courgeau & Lelievre,
1991). Individual life histories are considered as a continuumof events
of various nature involving family, housing, occupation, health, etc.
This technique allows the study of the occurrence of different types of
events or situations and their interactions, and enables a comparison
of different periods in a person’s life-course: for example, a patient’s
situation or life events before and after HIV diagnosis and anti-
retroviral initiation. However, as AIDS is a fatal disease, there is
a selection bias of respondents towards survivors.
Interview process
After explaining the purpose of the study and topics covered, all
HIV infected adults registered in the hospitals, aged >18 years, non
Table 1
Comparison of the demographic and HIV characteristics of non-respondents and
respondents.
Non-respondents Respondents p Value
N¼ 65 N¼ 513
Sex % %
Men 53.9 47.0 0.296
Women 46.1 53.0
Current agea (in years)
20–34 30.7 25.0 0.120
35–39 35.5 25.1
40–44 16.1 23.6
45 17.7 26.3
Antiretroviral treatment
Thai generic ARV combination 76.9 79.7 0.599
Others 23.1 20.3
Patient’s immune status
CD4< 50 cells/mm3 before
ARV initiationb
52.8 45.6 0.504
CD4 200 cells/mm3 after
ARV treatmentc
87.7 82.6 0.399
Reasons given for not respondingd
Working 60.9
Concern about disclosure risk 21.7
Otherse 17.4
HIV status disclosure 63.1 84.4 <0.001
Median Range Median Range p Value
Age (in years) 36.7 19–58 40.0 23–70 0.015
CD4 before ARV initiation (cells/mm3) 37.0 0–385 60.0 0–508 0.194
CD4 after ARV treatment (cells/mm3) 381.0 0–904 352.0 6–1343 0.465
a N¼ 62 non-respondents, N¼ 513 respondents.
b CD4 cell count before ARV, as recorded in the hospital ﬁle. N¼ 61 non-
respondents, N¼ 480 respondents.
S. Le Cœur et al. / Social Science & Medicine 69 (2009) 846–853848perinatally infected,1 and receiving antiretroviral treatments were
offered the opportunity to be interviewed for the study. Interviews
were conducted on a one-to-one basis in a private room dedicated
for the study. In the interview process, participants were informed
that all answers to the interview were strictly conﬁdential and
completely anonymous. It was stressed that participants were free
to decline answering any questions and that there were no good or
bad answers. After this introduction, willing participants were
asked to provide written informed consent. Respondents were
reimbursed for their transport costs and time. However, reim-
bursement was not used as an incentive, and the small sum (200
Baht or approximately US$5) was presented at the end of the
interview. The interview was based on a standard questionnaire,
and all dated events or periods of life were recorded on a calendar
sheet (Lelie`vre & Vivier, 2001). The median duration of the inter-
views was 50 min (ranging from 25 to 132 min).
Study setting and study population
The four community hospitals were selected based on their
long-term provision of antiretroviral treatments, mostly since
2002. Consequently, they treat a large number of adults and are
representative of community hospitals in semi-rural/sub-urban
areas of the Northern region.
From August to November 2007, all adult patients on anti-
retroviral treatment at participating hospitals were contacted for
an interview. Data on the socio-demographic (age, gender), clinical
characteristics (disease stage as indicated by the immunologic
status, as assessed by themost recent CD4 count, in cells/mm3, as of
the interview date and based on hospital records, and treatment
regimen) and HIV disclosure status of both respondents and non-
respondents were collected and compared.
Issues explored
We analyzed data from the life-event history survey exploring
the following issues:
(1) Family history: all successive unions, births, separation and
death of spouses, children; (2) Education; (3) Health: disease his-
torydmode of infection, date of diagnosis; disease stage as
assessed by the immunologic status before and after antiretroviral
treatment (again assessed by CD4 cell count before treatment
initiation, based on hospital records); treatment history, date of
antiretroviral initiation, type of treatment; overall appreciation of
health status before and after antiretrovirals.
Statistical analysis
Descriptive statistics were performed using Stata version 9.
The percentages were compared using a Pearson’s chi-square test
or a Fisher’s exact test according to the sample distribution. Means
and medians were compared using the student t test, and Kruskal-
Wallis test, respectively (medians and Kruskal-Wallis tests were
only applied to variables with sufﬁcient value range).
Ethical considerations
The studywas reviewed and approved by the Ethics Committee of
Chiang Mai University, Faculty of Associated Medical Sciences. Inter-
viewerswerepsychiatricnurses,who receivedspeciﬁc trainingon the
life-event history survey process and HIV/AIDS counselling.1 Per protocol, individuals with perinatal infections had to be excluded so as to
ensure a homogeneous study population. However, among patients aged> 18
years, there were no cases of perinatal infection.Results
Atotal of 578patientson antiretroviral treatmentswere contacted
for an interview; 513 agreed to participate, a response rate of 89%.Population characteristics
Socio-demographic and clinical characteristics of respondents
and non-respondents are reported in Table 1. There were slightly
more men non-respondents than women (54% versus 46%,
respectively), but the difference was not statistically signiﬁcant
(p¼ 0.296). Non-respondents were younger than respondents
(median age of 37 versus 40 years respectively, p¼ 0.015). Immune
status of the patients, before and after antiretroviral treatment, and
treatment regimen were similar among the two groups. This indi-
cates that there was no self-selection of the respondents according
to their disease stage. Among the reasons provided for not
participating in the study, unavailability due to work was reported
by 61% of non-respondents while conﬁdentiality concerns was
reported by 22%. This is consistent with data on serostatus disclo-
sure, showing non-respondents to be more reluctant to disclose
their HIV status compared to respondents (37% versus 16%
respectively, p< 0.001).
Data on the socio-demographic characteristics of the respon-
dents by gender are provided in Table 2. The sex distribution was
relatively balanced, with slightly more women than men, 53%
versus 47%, respectively. Themean age of participants at the time of
interview was 40 years for both sexes. Overall women had a lowerc Most recent CD4 cell count, as recorded in the hospital ﬁle. N¼ 60 non-
respondents, N¼ 480 respondents.
d N¼ 46 non-respondents (9 non-respondents did not give any reason).
e Including 2 patients who did not want to be interviewed; 3 could not come to
the hospital because of illness, 3 who forgot to come to their appointment.
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S. Le Cœur et al. / Social Science & Medicine 69 (2009) 846–853 849education level than men (p¼ 0.003): 27% of women attended
secondary school or more compared to 39% of men. This reﬂects the
gender difference in education in the adult population of this age
group in northern Thailand (National Statistical Ofﬁce, 2007). The
median individual income were 4000 baht for men (US$100)
compared to 3000 baht for women (US$75) (p< 0.001). This is
within the low income range for Thailand (National Statistical
Ofﬁce, 2007). The vast majority of the patients (91%) were receiving
treatment under the universal coverage system with no difference
by gender (Table 2).
Characteristics relating to marital life and children are outlined
in Table 3. ‘‘Spouses’’ were deﬁned as people living in a cohabiting
union for more than 6 months, mostly in marriage settings. The
mean number of spouses reported was lower for men than women
(1.5 versus 1.8, p< 0.001), although there was awider range in men
compared to women (0 to 12 spouses versus 0 to 4 spouses,
respectively). A much higher proportion of men reported never
having a spouse (13.3%) compared to only one woman (0.4%).
Importantly, among the respondents who ever had a spouse,
women were more likely to have experienced a spouse death (64%
versus 22%, p< 0.001), while men were more likely to have been
divorced or separated (92% versus 74%, p< 0.001). Sixty-ﬁve
percent of women had had more than one spouse compared to 38%
of men. Whether the second union occurred before or after
widowhood – mostly AIDS-related – needs to be investigated
further. In a previous study in Thailand performed at a time when
antiretroviral treatments were not available, we observed that HIV
infected persons often to remarry within the people living with HIV
networks (Le Cœur, Im-Em, Koetsawang, & Lelie`vre, 2005).
The average number of children was signiﬁcantly different for
women and men (1.2 versus 0.7 respectively; p< 0.001). Less thanTable 3
Comparison by gender, of the marital and children history of the respondents.
All respondents Men Women p Value
N¼ 513 N¼ 241 N¼ 272
Number of spouse(s) % % %
0 6.4 13.3 0.4 <0.001
1 41.5 49.0 34.9
2 35.9 24.0 46.3
3 16.2 13.7 18.4
Experienced a spouse’s death(s) a
0 54.4 77.9 36.2 <0.001
1 45.6 22.1 63.8
Experienced a spouse’s separation(s)a
0 18.3 8.1 26.2 <0.001
1 44.8 56.0 36.2
2 36.9 35.9 37.6
Number of children
0 34.9 51.9 19.9 <0.001
1 38.0 30.3 44.9
2 27.1 17.8 35.2
Experienced a child death(s)b
0 91.9 89.7 93.1 0.316
1 8.1 10.3 6.9
Mean Range Mean Range Mean Range p Value
Number of spouse(s) 1.7 0–12 1.5 0–12 1.8 0–4 <0.001
Number of spouse’s
deaths
0.5 0–3 0.2 0–3 0.7 0–2 <0.001
Number of separations 1.3 0–12 1.4 0–12 1.2 0–4 0.002
Number of children 1.0 0–5 0.7 0–5 1.2 0–4 <0.001
a Number of respondents who ever had a spouse: N¼ 480 all respondents;
N¼ 209 men; N¼ 271 women.
b Number of respondents who ever had a child: N¼ 334 all respondents; N¼ 116
men; N¼ 218 women.
Table 4
Comparison by gender, of the age at HIV diagnosis, the mode of infection of the
respondents.
All respondents Men Women p Value
N¼ 513 N¼ 241 N¼ 272
Age at HIV diagnosis (in years) % % %
15-29 30.6 27.0 33.8 0.109
30-34 24.0 22.0 25.7
35-39 20.1 23.2 17.3
40 25.3 27.8 23.2
Year of the HIV diagnosis
<1999 28.8 24.4 32.7 <0.001
1999–2001 15.4 10.0 20.2
2002–2003 20.7 22.0 19.5
2004–2005 22.2 27.0 18.0
2006–2007 12.9 16.6 9.6
Reported mode of infectiona
Sexual 88.5 81.7 94.4 <0.001
Injected Drug Use 4.1 8.3 0.4
Medical procedure 3.9 5.0 3.0
Not sure/don’t know 3.5 5.0 2.2
Mean Range Mean Range Mean Range p Value
Age at HIV diagnosis
(in years)
34.4 17–66 35.0 18–66 33.8 17–62 0.110
a N¼ 510 Total respondents; N¼ 240 men; N¼ 270 women.
S. Le Cœur et al. / Social Science & Medicine 69 (2009) 846–853850a quarter of women had no children compared to more than half of
themen (20% versus 52% respectively, p< 0.001). We investigated if
these contrasting family situations could explain differences in HIV
test-seeking behaviors.Reasons for undergoing HIV test, route of infection
To better assess the difference in HIV test-seeking behavior by
gender, we analyzed the age of respondents at the time of HIV test,
the year of test and the reasons for having a test. In cases where
participants had more than one HIV test, this refers to the test
which ﬁrst conﬁrmed their HIV-positive status.
Women were about one year younger than men at the time of
HIV diagnosis (mean age 33.8 years versus 35.0 years, respectively,
p¼ 0.110) (Table 4). Interestingly, more women than men tested for
HIV before or during 2003, the turning point for the national scale-HIV symptoms
health problems
Men Women
Partner/child
had/died of HIV
Premarital
Antenatal test
Voluntary
testing
Job/Loan
blood donation
100 80 60 40 20 0 20 40 60 80 100
(%)
Fig. 1. Reasons for HIV testing among men and women.up of free access to antiretroviral treatment, while more men were
tested after this date (Table 4). This suggests that the scale-up of
antiretroviral treatment boosted health-seeking behavior for HIV
testing among men. As shown on Fig. 1, the reasons reported for
HIV testing differed signiﬁcantly according to gender (p< 0.001):
health problems in 65% of men versus 38% of women; spouse or
child death in 11% of men versus 34% of women; voluntary HIV
counselling and testing – with no speciﬁc reason reported – was
similar among men and women (7% and 8%, respectively); 9% of
men and 2% of women had the test for social reasons such as to take
a loan, a job application, blood donation or during military service.
Interestingly, antenatal testing accounted for 17% of HIV tests in
women compared to 7% in men. Premarital testing was the reason
for very few tests, only 1.5% of the tests in women and 2.0% in men.
These gender differences highlight that over two-thirds of men
(65%) underwent HIV testing due to health problems, i.e., when
symptomatic, while the majority of women (52%) sought an HIV
test in relation to either their spouse’s illness/death, or through
premarital/antenatal testing, at a time when they were generally
asymptomatic.
Table 4 shows the reported mode of infection: In both sexes, the
large majority were sexual transmission, injection drug use was
much higher in men (8.3%) than women (0.4%), which is consistent
with other studies from Thailand (Razak et al., 2003).
Antiretroviral treatment initiation
The mean age at antiretroviral initiation was 37.4 years for men
and 37.0 for women (p¼ 0.67) (Table 5). The delay between the
HIV-positive test and treatment initiation was about one year
shorter in men compared to women (p¼ 0.004). Interestingly,
before 2004, signiﬁcantly more women had started antiretroviral
treatment than men (42% versus 31.0%), while more men initiated
treatment after, when free access to treatment was widely avail-
able. Fifty-four percent of men initiated treatment within one year
of diagnosis, compared to 33% of women. This is most likely due to
the fact that more men were symptomatic at time of diagnosis,
while most women were tested earlier in the course of infection.
This was reﬂected in the clinical condition at time of initiation of
treatment: a higher proportion of men had CD4 cell count less than
50 cells/mm3 (55% in men versus 38% in women, p< 0.001) and
their median CD4 count was 45 cells/mm3 compared to 84 cells/
mm3 in women (p< 0.001) (Table 5). In contrast, the most recent
median CD4 count did not signiﬁcantly differ by gender, suggesting
comparable efﬁcacy of treatment. Finally, the more advanced
disease stage inmenwas also reﬂected in the patients’ health status
perception at time of treatment initiation, which was signiﬁcantly
poorer in men compared to women (p¼ 0.038) (Table 6).
Discussion
Our results show a higher proportion of women receiving anti-
retroviral treatments compared to men. While over-representation
of women has been reported in sub-Saharan Africa, where there are
generally higher proportions of women in need of treatment than
men (UNAIDS, 2006), it is surprising for Thailand where there is
a higher proportion of HIV infected men (UNAIDS & WHO, 2008).
Our ﬁndings are consistent with two reports on adults on anti-
retroviral treatment in Thailand, (Braitstein et al., 2008; Leusaree
et al., 2002), however a selection bias towards women is possible in
these studies partially linked with PMTCT-Plus programs.
A key strength of our study was that adults were treated in
a community hospital setting providing standard of care and that
wewere exhaustive in reaching all patients. The percentage of non-
respondents was low (about 10%) and when recalculating the sex-
Table 6
Comparison by gender, of the health status perception before and after ARV
treatment.
All respondents Men Women p Value
N¼ 513 N¼ 241 N¼ 272
% % %
Health status perception before ARV initiation
Very poor 27.7 33.2 22.8 0.038
Poor 28.4 29.1 27.9
Fair 23.0 20.3 25.4
Good 12.3 9.1 15.1
Very good 8.6 8.3 8.8
Health status perception after ARV treatment (current)
Very poor 0.5 0.4 0.7 0.784
Poor 5.4 6.6 4.4
Fair 27.7 26.6 28.7
Good 45.4 44.8 46.0
Very good 20.8 21.6 20.2
Table 5
Comparison by gender, of the age at ARV initiation, delay between HIV diagnosis and ARV initiation, and patient’s immune status before and after ARV initiation.
All respondents Men Women p Value
N¼ 513 N¼ 241 N¼ 272
Age at ARV initiation (in years) % % %
15-29 17.1 15.4 18.8 0.686
30-34 23.6 22.8 24.3
35-39 22.8 23.6 22.1
40 36.5 38.2 34.9
Year at ARV treatment initiation
<2002 9.8 9.4 9.9 0.028
2002–2003 27.0 21.6 32.0
2004–2005 40.2 46.2 34.9
2006–2007 23.0 22.8 23.2
Delay between HIV diagnosis and ARV initiationa
< 1 year 42.9 53.9 33.1 <0.001
1 year 12.1 11.6 12.4
2 to 4 years 16.6 11.2 21.3
5 to 7 years 14.4 9.5 18.8
 8 years 14.0 13.7 14.3
Duration of the ARV treatment
Less than 2 years 23.0 22.8 23.2 0.018
2 to 4 years 40.2 46.1 34.9
 5 years 36.8 31.1 41.9
Patient’s immune status
CD4 <50 cells/mm3 before ARV initiationb 45.6 55.3 37.6 0.001
CD4 200 cells/mm3 after ARV treatmentc 82.6 75.7 88.3 <0.001
Mean Range Mean Range Mean Range p Value
Age at ARV initiation (years) 37.2 18–66 37.4 20–66 37.0 18–62 0.666
Delay between HIV diagnosis and ARV initiation (years) 2.6 0–14 2.3 0–14 2.9 0–13 0.017
Duration of the ARV treatment (years) 3.1 0–13 2.9 0–13 3.2 0–13 0.051
CD4 before ARV initiation (cells/mm3) 60.0 0–508 45.0 0–508 84.0 0–417 <0.001
CD4 after ARV treatment (cells/mm3) 352.0 6–1343 304.0 6–1338 399.5 6–1343 0.314
a Total respondents N¼ 509; N¼ 238 men; N¼ 272 women.
b Total respondents N¼ 480; N¼ 219 men; N¼ 261 women.
c Total respondents N¼ 482; N¼ 226 men; N¼ 256 women.
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gender balance remains unchanged (52% women). One limitation
may be that, for conﬁdentiality reasons, some patients chose to be
treated in hospitals outside of their residence area or in private
hospitals and therefore were not included in this study. Under both
circumstances, patients would no longer receive free care and
would have to pay for the cost of the treatments by themselves,
options not readily available for a population whose income is
generally low, although men’s incomes are slightly higher than
women’s. This is because the cost of the cheapest antiretroviral
treatment is 1200 baht (US$30) permonth, not including the cost of
out-patient visits andmonitoring. However, our study population is
likely to be representative of adults receiving antiretroviral therapy
in public hospitals in semi-rural Northern Thailand. There are
regional variations in the HIV epidemic trends (UNAIDS & WHO,
2008), therefore one should be cautious in extrapolating the results
on gender balance to the rest of the country. A study on a random
sample of hospitals throughout the country would be ideal, but
problems of cost and logistics would have to be resolved.
Many factors at the population and individual level may explain
thegenderdistributionobserved inour study. At thepopulation level,
one should consider the evolving dynamics of the HIV epidemic, the
initial prioritizationofmothers for treatment andearlieraccess toHIV
testing for women. These issues are entangled with gender differ-
ences at the individual level in the reasons and timing to HIV testing.
Firstly, as explained in the introduction,womenwere late comers
in the epidemic: the HIV epidemic wave among women in the
general population started a few years after the epidemic wave
among men and was of a lower magnitude. Therefore the mortality
peak occurred earlier and reached a higher level among men(Surasiengsunk et al., 1998). This was conﬁrmed in our study by the
higher proportion ofwomen (64%)who experienced a spouse death,
mostly assumed to be AIDS-related, comparedwithmen (22%). Due
to this time lag, it is possible that, in the course of the epidemic, we
stand precisely at a time when there is a diminishing gap between
the number of surviving men and women in need of treatment,
particularly in northernThailand,whichwas theﬁrst regionaffected
by the HIV epidemic and the most hard hit (Surasiengsunk et al.,
1998). In the absence of reliable data on the HIV prevalence by age
and gender in the general population for the ChiangMai region, it is
difﬁcult to assess the extent to which men are underrepresented in
our population on antiretroviral treatment. However, as there are
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epidemiologic factor does not fully explain the gender balance of
patients on antiretroviral treatment.
Secondly, the initial prioritization of HIV infected mothers for
antiretroviral treatment may partly explain the lower proportion of
men in the care system. Indeed, at a time when antiretroviral
treatments were limited, the Access to Care program, ﬁrst priori-
tized mothers, thenwomenmostly seen as victims of the epidemic,
and lastly men who were perceived as those who brought HIV into
the family/community. This is conﬁrmed by our data showing that
before 2003, when access to antiretrovirals was severely limited,
patients who received therapy were mostly women.
A third factor may be the earlier HIV diagnosis and treatment
initiation in thecourseof thediseaseobserved inwomencompared to
men. Indeed, symptomatic patients represent only the tip of the
iceberg, i.e., 10–20% of the HIV infected population. Asymptomatic
patients are more numerous and generally unaware of their HIV
status. Therefore, earlier diagnosis and treatment initiation contrib-
utes towards a higher proportion of women on antiretrovirals.
One key strength in our study methodology, retracing the life
histories of the patients, is the ability to assess gender differences in
access to treatment but also to disentangle their relationships to
access to HIV testing at the individual level.
Men and women underwent HIV testing in very different
circumstances. The large majority of women in this study had been
married and had children while men were more likely to never had
a spouse and children. This key difference in family situation may
partly explain the gender differences in HIV test-seeking behavior. As
partof their family responsibilities, as inmost countries,womenhave
more contact with the health care system, where HIV testing is more
likely to be suggested to them (Mane&Aggleton, 2001). For example,
over one-third ofwomenwere tested forHIVwhile caringor grieving
for a spouse or child, and interestingly, more women (47.4%) whose
spouse had passed away reported that they were tested because of
their spouse’s death compared to men (36.1%) in the same circum-
stances.Womenareoftenunder signiﬁcant social and familypressure
to be tested following a suspected AIDS-related spousal death,
particularly in semi-rural villages, hit hard by the epidemic, as they
are assumed to be HIV infected unless proven otherwise.
During their life-course, women also have access to HIV testing
during pregnancy and uptake for testing at this point is very high in
Thailand (Amornwichet et al., 2002). This was the reason for HIV
testing in 17% of women in this study, enabling them to be identiﬁed
and followed up prior to onset of AIDS-related disease. The strong
incentive to accept the routine HIV testing during pregnancy to
preserve the child’s healthdat a time when PMTCT is widely avai-
labled may help overcome women’s own fear of being tested. The
PMTCT-Plus strategy attempts to extend this incentive from ‘‘moth-
erhood’’ onto ‘‘parenthood’’, aiming at protecting the welfare of the
family as a whole and targeting future fathers for HIV testing.
However, our data show that although a non-negligible proportion of
men (7%)underwentHIV testingduring their spouse’s pregnancy, the
majority of men had no children and a signiﬁcant proportion had
never had a spouse, and therefore would be excluded from such tar-
geted interventions.
In contrast, two-thirds of men underwent HIV testing due to their
own health problems, often when symptomatic. A small proportion
of men (4%) were tested under institutional circumstances – job or
loan application, to become a member of an association, or at mili-
tary service. These policies, discriminatory in essence, and where
conﬁdentiality is not systematically protected, generate fear of
testing in the population and do not improve people’s access to
treatment as there is no referral to health care services for follow-up.
To ensure equal access to HIV care, interventions to improve
access to and uptake of voluntary HIV testing should be promoted.Indeed, contrary to women who are offered testing while already
inside the medical setting, somehow captive of it, for men, testing
requires a more personal motivation. Interestingly, our data indi-
cate the percentage of patients diagnosed through voluntary
testing to be similar among men and women, when ideally a larger
proportion of men should be tested in this setting due to lack of
alternative systematic channels.
Finally, other barriers to HIV testing and care such as low risk
perception of disease prognosis, poor access to medical care, lack of
social support, and actual or anticipated HIV/AIDS-related stigma
have been mentioned (Krawczyk et al., 2006; Mane & Aggleton,
2001; Muula et al., 2007). For example, Muula and colleagues
(Muula et al., 2007) argue that in sub-Saharan countries, women
are less stigmatized when seeking HIV testing as it is widely
perceived that women acquired HIV from a spouse, while men are
perceived to have acquired the infection outside of marriage. In
addition, HIV test-seeking behavior was perceived as an expression
of weakness in some settings where male strength was expected
(Greig & Lang, 2000). Further barriers may include denial of the risk
of HIV infection or fear of conﬁdentiality breach. While such
obstacles probably apply in Thailand, qualitative research is needed
to further assess their level of inﬂuence on access to HIV testing and
care and how they may be overcome.
In our study, women appear to have a double advantage in
both diagnosis and treatment. However, if men had been diag-
nosed and treated earlier, HIV transmission to their spouse may
have been avoided and their spouse may not have been widowed.
In terms of policy implications, there is an urgent need for
a concerted effort to promote voluntary HIV counselling and
testing both inside and outside of the family setting, with inter-
ventions speciﬁcally targeted for men. Both women and men
stand to beneﬁt from lessening of gender stereotypes and their
attached stigma, as it would ensure better equity in the access to
antiretroviral treatments.
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